跳至主要内容
临床试验/JPRN-jRCTs051180180
JPRN-jRCTs051180180
已完成
4 期

Prospective randomized trial to compare two treatment regimens of rituximab for adult refractory nephrotic syndrome - OPTIMALNS

Hayashi Terumasa0 个研究点目标入组 64 人2019年3月26日

概览

阶段
4 期
干预措施
未指定
疾病 / 适应症
nephrotic syndrome
发起方
Hayashi Terumasa
入组人数
64
状态
已完成
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2019年3月26日
结束日期
待定
最后更新
2年前
研究类型
Interventional
性别
All

研究者

发起方
Hayashi Terumasa

入排标准

入选标准

  • 1\) Patients who have developed nephrotic syndrome at age less than 18 years old and have been dependent to steroid alone or a combination with calcineurin inhibitors.
  • 2\) Patients who have developed nephrotic syndrome at 18 years old or older and have been dependent or resistant to steroid alone or a combination with calcineurin inhibitors and have been complicated with adverse effects of these drugs (e.g., diabetes, morbid fracture).
  • 3\) Patients diagnosed by renal biopsy as having minimal change disease or focal segmental glomerulosclerosis.
  • 4\) Patients who are at least 20 years old when they give informed consent.

排除标准

  • 1\) Patients diagnosed by renal biopsy as having any pathology other than minimal change disease or focal segmental glomerulosclerosis.
  • 2\) Patients with malignant disease or hematological disease.
  • 3\) Patients who are or may be pregnant, breast\-feeding or hope to be pregnant during the study period.

结局指标

主要结局

未指定

相似试验